Clear Cell Renal Cell Carcinoma With a Poorly-Differentiated Component: A Novel Variant Causing Potential Diagnostic Difficulty

被引:0
|
作者
Taneja, Kanika [1 ]
Cheng, Liang [2 ]
Al-Obaidy, Khaleel [2 ]
Kao, Chia-Sui [3 ]
Barletta, Justine [4 ]
Howitt, Brooke [3 ]
Wasco, Matthew [5 ]
Palanisamy, Nallasivam [1 ]
Gupta, Nilesh [1 ]
Rogers, Craig [1 ]
Carskadon, Shannon [1 ]
Chen, Ying-Bei [6 ]
Antic, Tatjana [7 ]
Tretiakova, Maria [8 ]
Williamson, Sean [1 ]
机构
[1] Henry Ford Hlth Syst, Detroit, MI USA
[2] Indiana Univ Sch Med, Indianapolis, IN 46202 USA
[3] Stanford Univ, Sch Med, Stanford, CA 94305 USA
[4] Harvard Med Sch, Brigham & Womens Hosp, Boston, MA 02115 USA
[5] St Joseph Mercy Hosp, Ann Arbor, MI 48104 USA
[6] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
[7] Univ Chicago, Chicago, IL 60637 USA
[8] Univ Washington, Seattle, WA 98195 USA
关键词
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
965
引用
收藏
页数:2
相关论文
共 50 条
  • [41] Differential diagnostic of renal clear cell carcinoma using ploidometry
    Fedorina, Tatiana
    Pleshivcev, Michael
    VIRCHOWS ARCHIV, 2007, 451 (02) : 123 - 123
  • [42] MicroRNAs as prognostic and diagnostic biomarkers in renal clear cell carcinoma
    Waller, T.
    Jung, Monika
    Kempkensteffen, Carsten
    Miller, Kurt
    Schaefer, Annika
    Stephan, Carsten
    EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2009, 14 : 117 - 118
  • [43] Identification of novel epigenetic markers for clear cell renal cell carcinoma
    Dalgin, Gul S.
    Drever, Michele
    Williams, Tara
    King, Thomas
    DeLisi, Charles
    Liou, Louis S.
    JOURNAL OF UROLOGY, 2008, 180 (03): : 1126 - 1130
  • [44] Unlike in clear cell renal cell carcinoma, KRAS is not mutated in multilocular cystic clear cell renal cell neoplasm of low potential
    Maria Rosaria Raspollini
    Francesca Castiglione
    Guido Martignoni
    Liang Cheng
    Rodolfo Montironi
    Antonio Lopez-Beltran
    Virchows Archiv, 2015, 467 : 687 - 693
  • [45] VNN3 is a potential novel biomarker for predicting prognosis in clear cell renal cell carcinoma
    Ha, Mihyang
    Jeong, Hoim
    Roh, Jong Seong
    Lee, Beomgu
    Lee, Dongjun
    Han, Myoung-Eun
    Oh, Sae-Ock
    Sohn, Dong Hyun
    Kim, Yun Hak
    ANIMAL CELLS AND SYSTEMS, 2019, 23 (02) : 112 - 117
  • [46] TEK is a novel prognostic marker for clear cell renal cell carcinoma
    Ha, M.
    Son, Y. R.
    Kim, J.
    Park, S. M.
    Hong, C. M.
    Choi, D.
    Kang, W.
    Kim, J. H.
    Lee, K. J.
    Park, D.
    Han, M. E.
    Oh, S. O.
    Lee, D.
    Kim, Y. H.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2019, 23 (04) : 1451 - 1458
  • [47] Unlike in clear cell renal cell carcinoma, KRAS is not mutated in multilocular cystic clear cell renal cell neoplasm of low potential
    Raspollini, Maria Rosaria
    Castiglione, Francesca
    Martignoni, Guido
    Cheng, Liang
    Montironi, Rodolfo
    Lopez-Beltran, Antonio
    VIRCHOWS ARCHIV, 2015, 467 (06) : 687 - 693
  • [48] A PARTIAL RESPONSE IN A POORLY DIFFERENTIATED RENAL CELL CARCINOMA PATIENT TREATED WITH PAZOPANIB
    Di Pietro, Francesca Romana
    Roberto, Michela
    Bassanelli, Maria
    Giacinti, Silvana
    Poti, Giulia
    Macrini, Serena
    Aschelter, Anna Maria
    Marchetti, Paolo
    ANTICANCER RESEARCH, 2018, 38 (04) : 2488 - 2489
  • [49] Ultrastructural observations on mitochondria and microvesicles in renal oncocytoma, chromophobe renal cell carcinoma, and eosinophilic variant of conventional (clear cell) renal cell carcinoma
    Tickoo, SK
    Lee, MW
    Eble, JN
    Amin, M
    Christopherson, T
    Zarbo, RJ
    Amin, MB
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2000, 24 (09) : 1247 - 1256
  • [50] Novel diagnostic value of driver gene transcription signatures to characterise clear cell renal cell carcinoma, ccRCC
    Ujfaludi, Z.
    Kuthi, L.
    Pankotai-Bodo, G.
    Banko, S.
    Sukosd, F.
    Pankotai, T.
    VIRCHOWS ARCHIV, 2022, 481 (SUPPL 1) : S306 - S306